stroke prevention & atrial fibrillation trial
Jump to navigation
Jump to search
Introduction
5-fold increased risk of cardiac death among patients with congestive heart failure (CHF) also receiving antiarrhythmic agents. The increased risk was greatest in those patients with structural heart disease & left ventricular ejection fraction of < 40%.
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998